Related Experiment Video
Updated: Apr 18, 2026
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Identification of dysregulated microRNAs in triple-negative breast cancer (review)
Fang Yang1, Wenwen Zhang1, Yan Shen1
1Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, P.R. China.
Abstract:
Triple-negative breast cancer (TNBC) is defined by the absence of expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). TNBC exhibits a more aggressive phenotype and a poorer clinical outcome compared to other breast cancer subgroups, accounting for 15-20% of total breast cancer cases. To date, the treatment strategies for TNBC are limited to surgery, chemotherapy and radiation, owing to the lack of effective therapeutic targets. Therefore, it is important to identify specific targets for TNBCs. MicroRNAs (miRNAs), a family of small non-coding RNAs regulating gene expression, are an emerging class of regulators of various biological processes, including cell proliferation, invasion, epithelial-mesenchymal transition (EMT) and drug resistance. Actually, miRNAs may serve as a novel therapeutic target in TNBC, and here we review current correlated researches and provide our own profiling results for the miRNAs expressed in TNBC cell lines. The present study offers an additional insight into the potential miRNAs involved in the regulation of TNBC.
Insights
Triple-negative breast cancer (TNBC) lacks specific targets, limiting treatment options. This study explores microRNAs (miRNAs) as potential therapeutic targets for aggressive TNBC, offering new insights into their regulatory roles.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype lacking ER, PR, and HER2 expression.
- Current TNBC treatments are limited to surgery, chemotherapy, and radiation due to a lack of targeted therapies.
- Identifying novel therapeutic targets is crucial for improving TNBC patient outcomes.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) as potential therapeutic targets in TNBC.
- To review current research on miRNAs in TNBC pathogenesis and progression.
- To present novel miRNA profiling data from TNBC cell lines.
Main Methods:
- Literature review of miRNA involvement in TNBC.
- miRNA expression profiling in TNBC cell lines.
Main Results:
- miRNAs are emerging regulators of key cancer processes like proliferation, invasion, and drug resistance.
- Profiling identified specific miRNAs expressed in TNBC cell lines.
- These findings suggest miRNAs' potential as biomarkers and therapeutic targets for TNBC.
Conclusions:
- miRNAs represent a promising avenue for novel therapeutic strategies in TNBC.
- Further research into miRNA regulation can enhance understanding and treatment of TNBC.
- This study contributes to identifying specific miRNA targets for TNBC intervention.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs